Choanal atresia associated with tracheoesophageal fistula: the spectrum of carbimazole embryopathy.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 21807695.
- Also identified by DOI 10.1542/peds.2010-0945.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
This article focuses on the case of a newborn infant boy with bilateral choanal atresia, tracheoesophageal fistula, and bilateral fifth-finger clinodactyly. This infant had been exposed to carbimazole in utero during the treatment of maternal Graves disease. Teratogenic defects caused by carbimazole were recently recognized, and their phenotypes have been defined. Choanal atresia, esophageal atresia, athelia or hypothelia, developmental delay, hearing loss, and dysmorphic facial features have all been reported. To our knowledge, this is the first documented case of tracheoesophageal fistula without esophageal atresia (H type). Knowledge of the teratogenic potential of carbimazole is important when managing Graves disease in women of childbearing age.
Medical subject headings
- Antithyroid Agents
- Carbimazole
- Choanal Atresia
- Prenatal Exposure Delayed Effects
- Tracheoesophageal Fistula